CANY
MR

Caxton Associates (New York)’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Caxton Associates (New York)’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-54,200
Closed -$1.43M – 220
2014
Q4 		$1.43M Buy
+54,200
New +$1.59M 0.11% 103

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Caxton Associates (New York)'s MR Position: Q1 2015 in Review

Caxton Associates (New York) sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2015, closing a stake of 54,200 shares — an estimated $1.43M sold.

Caxton Associates (New York) first reported a position in MR in Q4 2014 and held it in 1 quarter. The position peaked at $1.43M in Q4 2014. 124 funds tracked by Wall St. Rank hold MR as of Q1 2015.

  • Caxton Associates (New York) reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2015 after selling out during the quarter.
  • Caxton Associates (New York) sold 54,200 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2015, an estimated $1.43M.
  • Caxton Associates (New York) first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2014 and held it in 1 quarter.
  • Caxton Associates (New York)'s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.43M in Q4 2014.
  • 124 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2015.

Based on Caxton Associates (New York)'s 13F filing for Q1 2015, filed 15 May 2015.